Tanshinone IIA impairs platelet function and thrombus formation
Journal of Thrombosis and Haemostasis · 2026
DOI: 10.1016/j.jtha.2026.06.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026. Verfasst von Wei Gu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Xuzhou First People's Hospital and The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou, China. Hauptthemen laut MEDLINE: Abietanes, Blood Platelets, Thrombosis, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Xuzhou Medical University.
Abstract (Originalsprache)
BACKGROUND: Tanshinone IIA (T-IIA) is a fat-soluble active ingredient derived from the traditional Chinese medicine Danshen and possesses cardioprotective property. However, its exact role in platelet function is unknown. OBJECTIVES: This study investigated T-IIA's role in platelet aggregation, granules release, spreading, clot retraction, as well as in vivo hemostasis and thrombus formation. METHODS: Human platelets were treated with different doses of T-IIA (10, 50, and 100 μM) to measure platelet function and activation. In addition, T-IIA was administrated into wild-type mice to evaluate hemostasis and thrombus formation. RESULTS: T-IIA significantly impaired platelet aggregation, adenosine triphosphate secretion, P-selectin expression, and spreading and clot retraction dose dependently without affecting the expression profiles of αIIbβ3 and glycoprotein VI or Ibα. Administration of T-IIA significantly prolonged mice tail bleeding time and inhibited arterial and venous thrombosis. Further analysis showed that T-IIA dose dependently reduced platelet reactive oxygen species generation. Quantitative proteomic and phosphoproteimic assays analyzing T-IIA-treated vs vehicle-treated platelets after stimulation identified dysregulated phosphorylation of several proteins, which were enriched in platelet activation. Among the downregulated phosphoproteins, Rho-associated protein kinase (ROCK)1, integrin β3, and talin1 exhibited the lower fold change of phosphorylation in T-IIA-treated platelets compared with those in vehicle-treated platelets. Consistently, T-IIA treatment inhibited the phosphorylation of ROCK1, p47phox, integrin β3, and talin1 in activated platelets. CONCLUSION: T-IIA impairs platelet function and thrombosis via inhibition of several signaling pathways including ROCK1/p47phox, β3, and talin1, implying that T-IIA may represent a promising therapeutic candidate for treating thrombotic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Xuzhou First People's Hospital and The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou, China.
- Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China. Electronic address: jianlin.qiao@gmail.com.
Förderung
- Xuzhou Medical University
Zitieren
APA
Gu, W., Hu, H., Zhu, W., Li, Y., Hu, L., & Qiao, J. (2026). Tanshinone IIA impairs platelet function and thrombus formation. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2026.06.002
Vancouver
Gu W, Hu H, Zhu W, Li Y, Hu L, Qiao J. Tanshinone IIA impairs platelet function and thrombus formation. Journal of Thrombosis and Haemostasis. 2026. doi:10.1016/j.jtha.2026.06.002
BibTeX
@article{Gu2026,
author = {Gu, Wei and Hu, Haibo and Zhu, Wei and Li, Yuanyuan and Hu, Luan and Qiao, Jianlin},
title = {Tanshinone IIA impairs platelet function and thrombus formation},
journal = {Journal of Thrombosis and Haemostasis},
year = {2026},
doi = {10.1016/j.jtha.2026.06.002}
}
EUVIMED